Inventor · disambiguated record
Jiye Shi
Also filed as: SHI JIYE
13 granted patents·7 pending applications·208 citations·filing 2004–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0197US7578999B2Antibodies specific for sclerostinCELLTECH R & D INC·Filed 2006·Granted Aug 25, 2009·66 cites·23 claims
- 0297US7381409B2Antibodies specific for sclerostin and methods of screening and use thereforCELLTECH R & D INC·Filed 2004·Granted Jun 3, 2008·68 cites·16 claims
- 0396US7868134B2Immunogenic peptides derived from sclerostinUCB MFG INC·Filed 2008·Granted Jan 11, 2011·49 cites·20 claims
- 0494US9011856B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Apr 21, 2015·7 cites·30 claims
- 0594US8992911B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Mar 31, 2015·7 cites·17 claims
- 0689US8563271B2Antibodies specific for sclerostin and methods for increasing bone mineralizationWINKLER DAVID G·Filed 2012·Granted Oct 22, 2013·7 cites·28 claims
- 0789US2024209075A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB PHARMA SA·Filed 2023·Application pending·0 cites
- 0879US7985834B2Compositions and methods for increasing bone mineralizationCELLTECH R & D INC·Filed 2009·Granted Jul 26, 2011·2 cites·5 claims
- 0978US11702468B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2019·Granted Jul 18, 2023·0 cites·2 claims
- 1073US9045537B2Antibodies specific to IL-17A and IL-17FUCB PHARMA SA·Filed 2014·Granted Jun 2, 2015·1 cites·5 claims
- 1170US9771420B2Methods of treating an IL-17A mediated pathological conditionUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 26, 2017·1 cites·7 claims
- 1268US2018072801A1Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2017·Application pending·0 cites
- 1367US11942188B2Obtaining an improved therapeutic ligandUCB Biopharma SRL·Filed 2020·Granted Mar 26, 2024·0 cites·19 claims
- 1466US9657095B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2015·Granted May 23, 2017·0 cites·22 claims
- 1561US2011206677A1Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB MFG INC·Filed 2011·Application pending·0 cites
- 1660US2011195453A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB MFG INC·Filed 2010·Application pending·0 cites
- 1760US2018037646A1Epitopes of il-17a and il-17f and antibodies specific theretoUCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 1859US2011206678A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB MFG INC·Filed 2011·Application pending·0 cites
- 1957US2016125124A1Obtaining an Improved Therapeutic LigandUCB BIOPHARMA SPRL·Filed 2014·Application pending·0 cites
- 2044US12327613B2De novo antibody designUCB Biopharma SRL·Filed 2016·Granted Jun 10, 2025·0 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →